We are live on ! Find out more
SR

Syntax Research Portfolio holdings

AUM $157M
1-Year Est. Return 16.51%
This Fund
S&P 500
This Quarter Est. Return
+7.32%
1 Year Est. Return
+16.51%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$141M
AUM Growth
-$4.04M
Cap. Flow
-$11.9M
Cap. Flow %
-8.48%
Top 10 Hldgs %
46.39%
Holding
182
New
7
Increased
31
Reduced
30
Closed
12

Top Buys

1
TMO icon
Thermo Fisher Scientific
TMO
+$2.35M
2
ZTS icon
Zoetis
ZTS
+$2.21M
3
WTW icon
Willis Towers Watson
WTW
+$2.17M
4
PANW icon
Palo Alto Networks
PANW
+$2.16M
5
ACN icon
Accenture
ACN
+$2.03M

Top Sells

1
NTR icon
Nutrien
NTR
+$3.4M
2
AMT icon
American Tower
AMT
+$3.32M
3
NEM icon
Newmont
NEM
+$3.21M
4
COLD icon
Americold
COLD
+$2.6M
5
MRK icon
Merck
MRK
+$2.39M

Sector Composition

1 Technology 19.94%
2 Healthcare 5.03%
3 Industrials 4.92%
4 Financials 4.5%
5 Materials 4.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTW icon
26
Willis Towers Watson
WTW
$27.7B
$2.14M 1.52%
+6,988
New +$2.17M
TLT icon
27
iShares 20+ Year Treasury Bond ETF
TLT
$42.1B
$2.14M 1.52%
24,232
+18,670
+336% +$1.63M
ACN icon
28
Accenture
ACN
$87.9B
$1.99M 1.41%
+6,657
New +$2.03M
SLB icon
29
SLB Ltd
SLB
$70.3B
$1.82M 1.29%
53,817
-22,824
-30% -$792K
QUAL icon
30
iShares MSCI USA Quality Factor ETF
QUAL
$46.1B
$1.76M 1.25%
9,638
+758
+9% +$131K
NOC icon
31
Northrop Grumman
NOC
$74.1B
$1.5M 1.07%
+3,000
New +$1.47M
VALE icon
32
Vale
VALE
$60.4B
$1.36M 0.97%
140,000
-90,000
-39% -$848K
USMV icon
33
iShares MSCI USA Min Vol Factor ETF
USMV
$23.1B
$1.34M 0.95%
14,309
+7,697
+116% +$708K
ELV icon
34
Elevance Health
ELV
$80.9B
$1.17M 0.83%
+3,000
New +$1.21M
FMC icon
35
FMC
FMC
$1.4B
$1.09M 0.77%
26,000
-14,201
-35% -$564K
COP icon
36
ConocoPhillips
COP
$140B
$989K 0.7%
11,021
-243
-2% -$21.9K
BA icon
37
Boeing
BA
$169B
$946K 0.67%
4,514
-248
-5% -$46.8K
AMZN icon
38
Amazon
AMZN
$2.66T
$943K 0.67%
4,300
– –
OXY icon
39
Occidental Petroleum
OXY
$54.6B
$840K 0.6%
+20,000
New +$836K
RTX icon
40
RTX Corp
RTX
$261B
$759K 0.54%
5,199
-240
-4% -$32K
CVX icon
41
Chevron
CVX
$373B
$739K 0.52%
5,158
+702
+16% +$99K
APD icon
42
Air Products & Chemicals
APD
$65.8B
$678K 0.48%
2,405
+385
+19% +$105K
UPS icon
43
United Parcel Service
UPS
$100B
$656K 0.47%
6,503
+680
+12% +$66.9K
MDT icon
44
Medtronic
MDT
$106B
$569K 0.4%
6,523
+646
+11% +$54.8K
GOVT icon
45
iShares US Treasury Bond ETF
GOVT
$43.7B
$515K 0.37%
22,393
-565
-2% -$12.9K
BLK icon
46
Blackrock
BLK
$166B
$504K 0.36%
480
+34
+8% +$32.1K
TIP icon
47
iShares TIPS Bond ETF
TIP
$14.5B
$499K 0.35%
4,538
+62
+1% +$6.76K
BRK.B icon
48
Berkshire Hathaway Class B
BRK.B
$1.06T
$497K 0.35%
1,024
– –
EEM icon
49
iShares MSCI Emerging Markets ETF
EEM
$28B
$495K 0.35%
10,271
-12,494
-55% -$562K
LMT icon
50
Lockheed Martin
LMT
$117B
$484K 0.34%
1,044
+1
+0.1% +$468
1
2
3 4 5

Similar funds

BRWM
Blue Rock Wealth Management Winston-Salem, North Carolina $157M AUM 18.03% 1-Year Est. Return
SF
Seros Financial Tempe, Arizona $157M AUM 16.95% 1-Year Est. Return
AC
AlpenGlobal Capital Tahoe City, California $157M AUM
HEM
Henson-Edgewater Management Avon, Ohio $157M AUM
EP
Elkhorn Partners Omaha, Nebraska $157M AUM 11.91% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
TPBG
Turning Point Benefit Group Frederick, Maryland $157M AUM 20.14% 1-Year Est. Return
CFG
Certior Financial Group King Of Prussia, Pennsylvania $157M AUM 12.22% 1-Year Est. Return

Syntax Research's Q2 2025 Portfolio in Review

As of Q2 2025, Syntax Research held 182 positions worth $141M, down 2.8% from $145M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Syntax Research withdrew a net $11.9M in Q2 2025, closing 12 positions and reducing 30 holdings. Its most notable exit was Americold, an estimated $2.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, Syntax Research opened a new position in Zoetis worth $2.17M.

  • Syntax Research's largest Q2 2025 buy was Zoetis: 13,918 shares worth $2.17M.
  • Syntax Research added most to Thermo Fisher Scientific in Q2 2025, an estimated $2.35M increase.
  • Syntax Research's biggest Q2 2025 reduction was Nutrien, cutting an estimated $3.4M.
  • Syntax Research fully exited Americold in Q2 2025, selling an estimated $2.6M.
  • Syntax Research's ten largest holdings make up 46% of its $141M portfolio in Q2 2025.
  • Syntax Research opened 7 new positions and closed 12 in Q2 2025.
  • Syntax Research's portfolio value fell 2.8% quarter-over-quarter to $141M.

Based on Syntax Research's 13F filing for Q2 2025, filed 21 Jul 2025.